Lee's Pharmaceutical Holdings Ltd
F:L1PA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Lee's Pharmaceutical Holdings Ltd
F:L1PA
|
HK |
|
Narasaki Sangyo Co Ltd
TSE:8085
|
JP |
|
C
|
Citi Trends Inc
F:WW2
|
US |
|
K
|
Kapsch Trafficcom AG
XBER:BZ6
|
AT |
|
Dominion Lending Centres Inc
F:B6M
|
CA |
|
E
|
ESG Global Impact Capital Inc
OTC:ESIFF
|
CA |
|
P
|
Photo-Me International PLC
F:PHQ
|
UK |
|
Eurobio Scientific SA
PAR:ALERS
|
FR |
|
H
|
Huang Long Development Co Ltd
TPEX:3512
|
TW |
Wall St Price Targets
L1PA Price Targets Summary
Lee's Pharmaceutical Holdings Ltd
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is L1PA's stock price target?
Not Available
L1PA does not have any price targets made by Wall Street professionals.
What is the Gross Profit forecast for Lee's Pharmaceutical Holdings Ltd?
Projected CAGR
6%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 3 years is 6%.
What is the Pre-Tax Income forecast for Lee's Pharmaceutical Holdings Ltd?
Projected CAGR
27%
Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been -2%. The projected CAGR for the next 3 years is 27%.
What is the Net Income forecast for Lee's Pharmaceutical Holdings Ltd?
Projected CAGR
-9%
Over the last 14 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 2 years is -9%.